NASDAQ:FPRX - Five Prime Therapeutics Price Target & Analyst Ratings

-0.09 (-1.61 %)
(As of 07/23/2019 08:07 AM ET)
Today's Range
Now: $5.50
50-Day Range
MA: $6.06
52-Week Range
Now: $5.50
Volume231,118 shs
Average Volume479,294 shs
Market Capitalization$198.33 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Five Prime Therapeutics (NASDAQ:FPRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Five Prime Therapeutics in the last 12 months. Their average twelve-month price target is $21.3333, suggesting that the stock has a possible upside of 287.88%. The high price target for FPRX is $44.00 and the low price target for FPRX is $10.00. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.632.672.67
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $21.3333$21.3333$26.00$30.3750
Price Target Upside: 287.88% upside153.97% upside99.08% upside202.54% upside

Five Prime Therapeutics (NASDAQ:FPRX) Consensus Price Target History

Five Prime Therapeutics (NASDAQ:FPRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/3/2019Wells Fargo & CoDowngradeOutperform ➝ Market Perform$35.00 ➝ $10.00HighView Rating Details
5/29/2019Roth CapitalInitiated CoverageNeutral ➝ Neutral$10.00 ➝ $10.00MediumView Rating Details
4/12/2019GuggenheimInitiated CoverageBuy$24.00HighView Rating Details
2/27/2019CowenReiterated RatingBuyHighView Rating Details
1/17/2019WedbushUpgradeNeutral ➝ Outperform$16.00HighView Rating Details
9/13/2018Leerink SwannInitiated CoverageOutperform ➝ Outperform$24.00HighView Rating Details
8/20/2018CitigroupLower Price TargetBuy ➝ Buy$60.00 ➝ $44.00LowView Rating Details
6/28/2018Raymond JamesInitiated CoverageMarket PerformHighView Rating Details
6/15/2018JPMorgan Chase & Co.Initiated CoverageNeutral$19.00HighView Rating Details
5/10/2018Goldman Sachs GroupInitiated CoverageNeutral$20.00MediumView Rating Details
2/28/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$75.00 ➝ $60.00LowView Rating Details
2/28/2018NomuraLower Price TargetBuy ➝ Buy$94.00 ➝ $25.00HighView Rating Details
11/6/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$41.00 ➝ $50.00N/AView Rating Details
9/12/2017Jefferies Financial GroupReiterated RatingBuy$52.00HighView Rating Details
(Data available from 7/23/2017 forward)
This page was last updated on 7/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel